DPP4 was described as a main receptor for the Middle East respiratory syndrome (MERS) in 2012, and during the early days of the ongoing pandemic it was described as a coreceptor able to bind to the spike protein of SARS-CoV-2 [79]. This evidence concerns the gene DPP4 and Middle East respiratory syndrome.